Tu1693 LACTULOSE WITHDRAWAL CAN POTENTIATE BREAKTHROUGH OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS CONTROLLED WITH RIFAXIMIN PLUS LACTULOSE THERAPY: A POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
Bajaj, Jasmohan S., Vinay, Sundaram, Frenette, Catherine T., Heimanson, Zeev, Israel, Robert J., Sanyal, Arun J.Volume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)34306-7
Date:
May, 2020
File:
PDF, 1.32 MB
2020
File converter
More search results
More benefits 
